Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALYSSA BRIELLE BRION

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1356943013
CMS profile
10483890
Location
IRVING, TX

General Payments · PY2021–2023

$928.31

  • Reported across 48 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$364.33

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $364.33 16

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $238.63 10
Lilly USA, LLC $32.98 2
ABBVIE INC. $28.54 1
GlaxoSmithKline, LLC. $24.51 1
PFIZER INC. $19.98 1
SI-BONE, INC. $19.69 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $156.79 11
PY2022 $407.19 21
PY2023 $364.33 16

Payment records · PY2023 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $28.54 05/09/2023 Food and Beverage Undisputed 01/23/2026 1003224219 CMS
GlaxoSmithKline, LLC. $24.51 04/21/2023 Food and Beverage Undisputed 01/23/2026 1003824897 CMS
Lilly USA, LLC $17.99 03/24/2023 Food and Beverage Undisputed 01/23/2026 1032440105 CMS
Lilly USA, LLC $14.99 04/15/2023 Food and Beverage Undisputed 01/23/2026 1032691851 CMS
Novo Nordisk Inc $20.37 01/09/2023 Food and Beverage Undisputed 01/23/2026 1002487335 CMS
Novo Nordisk Inc $18.82 01/24/2023 Food and Beverage Undisputed 01/23/2026 1002487323 CMS
Novo Nordisk Inc $17.76 01/27/2023 Food and Beverage Undisputed 01/23/2026 1002487299 CMS
Novo Nordisk Inc $12.46 01/28/2023 Food and Beverage Undisputed 01/23/2026 1002487261 CMS
Novo Nordisk Inc $21.44 02/03/2023 Food and Beverage Undisputed 01/23/2026 1002487347 CMS
Novo Nordisk Inc $18.63 03/07/2023 Food and Beverage Undisputed 01/23/2026 1002487313 CMS
Novo Nordisk Inc $91.27 04/25/2023 Food and Beverage Undisputed 01/23/2026 1002487359 CMS
Novo Nordisk Inc $16.27 04/28/2023 Food and Beverage Undisputed 01/23/2026 1002487285 CMS
Novo Nordisk Inc $15.31 05/05/2023 Food and Beverage Undisputed 01/23/2026 1002487271 CMS
Novo Nordisk Inc $6.30 05/16/2023 Food and Beverage Undisputed 01/23/2026 1002487249 CMS
PFIZER INC. $19.98 03/04/2023 Food and Beverage Undisputed 01/23/2026 1049607925 CMS
SI-BONE, INC. $19.69 02/21/2023 Food and Beverage Undisputed 01/23/2026 1027768603 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.